GlaxoSmithKline has released long-term data showing that its biologic Nucala significantly decreased exacerbations in patients with severe, eosinophilic asthma as well as improvement in disease control. According to results of the COLUMBA trial, which […]
The European Medicines Agency has concluded that the risks linked with use of Biogen and AbbVie’s multiple sclerosis drug Zinbryta outweigh its benefits. The Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has confirmed that Zinbryta […]
Prime Minister Theresa May has revealed new plans to prevent thousands of cancer deaths and improve the detection of chronic diseases through greater use of artificial intelligence. In a speech later today, the PM […]
Amgen and Novartis’ Aimovig has become the first anti-CGRP therapy to win regulatory clearance in the US, winning approval for migraine prevention. The monoclonal antibody offers patients a novel therapeutic approach as the first […]
Novo Nordisk has announced an increased commitment to stem cell therapies and an expansion into other serious chronic diseases beyond type 1 diabetes. This comes after Novo Nordisk achieved a milestone in developing human […]